NM_014583.4:c.43-3313G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_014583.4(LMCD1):c.43-3313G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.378 in 151,988 control chromosomes in the GnomAD database, including 11,931 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.38 ( 11931 hom., cov: 33)
Consequence
LMCD1
NM_014583.4 intron
NM_014583.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.757
Publications
7 publications found
Genes affected
LMCD1 (HGNC:6633): (LIM and cysteine rich domains 1) This gene encodes a member of the LIM-domain family of zinc finger proteins. The encoded protein contains an N-terminal cysteine-rich domain and two C-terminal LIM domains. The presence of LIM domains suggests involvement in protein-protein interactions. The protein may act as a co-regulator of transcription along with other transcription factors. Alternate splicing results in multiple transcript variants of this gene. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.484 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LMCD1 | NM_014583.4 | c.43-3313G>A | intron_variant | Intron 1 of 5 | ENST00000157600.8 | NP_055398.1 | ||
| LMCD1 | NM_001278233.2 | c.-88-7761G>A | intron_variant | Intron 1 of 4 | NP_001265162.1 | |||
| LMCD1 | NM_001278234.2 | c.-38-3313G>A | intron_variant | Intron 1 of 4 | NP_001265163.1 | |||
| LMCD1 | NM_001278235.2 | c.43-3313G>A | intron_variant | Intron 1 of 4 | NP_001265164.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.378 AC: 57376AN: 151870Hom.: 11936 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
57376
AN:
151870
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.378 AC: 57379AN: 151988Hom.: 11931 Cov.: 33 AF XY: 0.369 AC XY: 27370AN XY: 74268 show subpopulations
GnomAD4 genome
AF:
AC:
57379
AN:
151988
Hom.:
Cov.:
33
AF XY:
AC XY:
27370
AN XY:
74268
show subpopulations
African (AFR)
AF:
AC:
10744
AN:
41428
American (AMR)
AF:
AC:
5075
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
1410
AN:
3466
East Asian (EAS)
AF:
AC:
293
AN:
5166
South Asian (SAS)
AF:
AC:
1057
AN:
4822
European-Finnish (FIN)
AF:
AC:
4286
AN:
10548
Middle Eastern (MID)
AF:
AC:
118
AN:
294
European-Non Finnish (NFE)
AF:
AC:
33178
AN:
67958
Other (OTH)
AF:
AC:
815
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1774
3547
5321
7094
8868
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
534
1068
1602
2136
2670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
489
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.